Delivery Order SPE2DB22D3501-SPE2DB25FVQ01
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Atorvastatin 20 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,093.56. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-competitive, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $3,278.97 to AmerisourceBergen Drug Corp for the supply of Atorvastatin 80 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of July 17, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...
- The Defense Logistics Agency's Medical Supply Chain awarded a $12,618.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 15, 2024, for the supply of Atorvastatin Calcium, a widely-used statin medication for cholesterol management. The contract, which represents a child delivery order under a larger indefinite delivery vehicle, was competitively awarded with no set-aside designation. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 80 mg Atorvastatin tablets. The $2,088.50 firm-fixed-price contract has an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities, including...
- The Defense Logistics Agency awarded a delivery order valued at $1,409.36 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Atorvastatin 40 mg, a generic statin medication commonly used for cholesterol management. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania. The order is for 4,564,097,707 units of Atorvastatin 10 mg tablets, a generic pharmaceutical product, with a ceiling value of $3,735.53. The delivery order has an ultimate completion date of March 28, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,049.14 firm-fixed-price contract is for the delivery of 4,560,272,823 units of 20 mg Atorvastatin tablets for medical use. The contract has an ultimate completion date of March 16, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) awarded a $1,584.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,651,931 units of Atorvastatin 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This is a $8,604.56 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,780 units of 80 mg Atorvastatin tablets, a cardiovascular medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred sixty-seven dollars and eighty-eight cents to Amerisourcebergen Drug Corporation for the provision of five hundred tablets of the generic pharmaceutical atorvastatin. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The delivery order has a period of performance from August 9, 2023 through August 10, 2023. As a major provider of pharmaceuticals and medical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVQ01Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Atorvastatin 80 mg tablets in unit dose packaging of 30 units, with a ceiling value of $1,671.03. This is a firm fixed price delivery order with no set-aside designation, executed competitively. The order is scheduled for ultimate completion by May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical supply transaction under the company's broader federal contract arrangements. This award is a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The company, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly fulfills such orders through the DLA Medical Supply Chain to support defense and veteran healthcare systems. The atorvastatin order exemplifies the routine therapeutic medications supplied through this vehicle to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 5/8/25 |